跳至主要内容
临床试验/ACTRN12624000420549
ACTRN12624000420549尚未招募2 期

CARGo: Investigating the Efficacy of Carbamazepine for the treatment of gonorrhoea in women

Gold Coast University Hospital0 个研究点目标入组 75 人开始时间: 2024年4月5日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Cis-gender women
  • Aged greater than or equal to 18 years old
  • Self-reported or confirmed sexual contact of Neisseria gonorrhoea (NG) infection
  • Willing to test and wait” for NG (ie. Not take any antibiotics which may treat NG) until results available
  • Willing to abstain from sex until completion of all study visits

排除标准

  • Any history of seizures
  • Symptoms suggesting NG infection (eg. Change in vaginal discharge, intermenstrual bleeding)
  • Symptoms suggesting complicated NG infection (eg. Pelvic inflammatory disease)
  • Test results suggesting NG infection (microscopy with Gram negative intracellular diplococci, positive N. gonorrhoea NAAT or NAAT) within the last 14 days
  • Have had unprotected sex with the index case of gonorrhoea within the last 7 days (window period for gonorrhoea test and potential false negative test)
  • Has received any antibiotics for the treatment of NG within the last 14 days
  • Any contraindication to receiving carbamazepine
  • Already taking carbamazepine or oxcarbazepine for existing health conditions
  • Taking concomitant medication which may be contraindicated or have significant interactions with carbamazepine
  • Currently or intending to become pregnant within the study period
  • Breastfeeding

研究者

发起方
Gold Coast University Hospital

相似试验

CARGo: Investigating the Efficacy of Carbamazepine... | 临床试验